Treatment of Cancer with TOR Kinase Inhibitors
US-2023338370-A1 · Oct 26, 2023 · US
This page is not indexed by search engines while we improve data quality.
Raymon Heather patents
Raymon Heather is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Raymon Heather |
| Total patents | 31 |
| First publication | Apr 7, 2016 |
| Latest publication | Oct 26, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-2023158035-A1 · May 25, 2023 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-11590139-B2 · Feb 28, 2023 · US
Treatment of cancer with tor kinase inhibitors
US-2022273650-A1 · Sep 1, 2022 · US
Cd47 antibodies and methods of use thereof
US-2021371522-A1 · Dec 2, 2021 · US
Treatment of cancer with TOR kinase inhibitors
US-11166950-B2 · Nov 9, 2021 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-2021128565-A1 · May 6, 2021 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-10940152-B2 · Mar 9, 2021 · US
Cd47 antibodies and methods of use thereof
US-2020255515-A1 · Aug 13, 2020 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-2020237768-A1 · Jul 30, 2020 · US
Recent patents
Latest publications not already listed above.
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-10646493-B2 · May 12, 2020 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-10576085-B2 · Mar 3, 2020 · US
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
US-10391092-B2 · Aug 27, 2019 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-10183019-B2 · Jan 22, 2019 · US
Treatment of cancer with tor kinase inhibitors
US-2018235960-A1 · Aug 23, 2018 · US
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
US-2018185361-A1 · Jul 5, 2018 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-9980963-B2 · May 29, 2018 · US
Treatment of cancer with TOR kinase inhibitors
US-9937170-B2 · Apr 10, 2018 · US
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
US-9937169-B2 · Apr 10, 2018 · US
Methods for treating cancer using TOR kinase inhibitor combination therapy
US-9782427-B2 · Oct 10, 2017 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-2017281633-A1 · Oct 5, 2017 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-9737541-B2 · Aug 22, 2017 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-2017182044-A1 · Jun 29, 2017 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-9630966-B2 · Apr 25, 2017 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-2017065583-A1 · Mar 9, 2017 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-2017042902-A1 · Feb 16, 2017 · US
Treatment of cancer with tor kinase inhibitors
US-2017027932-A1 · Feb 2, 2017 · US
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
US-9512124-B2 · Dec 6, 2016 · US
Treatment of cancer with dihydropyrazino-pyrazines
US-9505764-B2 · Nov 29, 2016 · US
Treatment of cancer with TOR kinase inhibitors
US-9493466-B2 · Nov 15, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Signal Pharm Llc | 29 |
| Celgene Corp | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 28 |
| A61K31/52 | 18 |
| A61K31/4985 | 17 |
| A61K31/5377 | 13 |
| C07D487/04 | 13 |